任世杰, 魏宏珂, 成欣欣, 王嘉琪, 乔晓婷, 王晓敏, 吕子玉, 曹朵. 西南凤尾蕨中一个新的倍半萜及其抗癌活性研究J. 药学学报, 2025, 60(5): 1485-1489. DOI: 10.16438/j.0513-4870.2024-1190
引用本文: 任世杰, 魏宏珂, 成欣欣, 王嘉琪, 乔晓婷, 王晓敏, 吕子玉, 曹朵. 西南凤尾蕨中一个新的倍半萜及其抗癌活性研究J. 药学学报, 2025, 60(5): 1485-1489. DOI: 10.16438/j.0513-4870.2024-1190
REN Shi-jie, WEI Hong-ke, CHENG Xin-xin, WANG Jia-qi, QIAO Xiao-ting, WANG Xiao-min, LÜ Zi-yu, CAO Duo. A new sesquiterpenes from Pteris wallichiana and its anticancer activityJ. Acta Pharmaceutica Sinica, 2025, 60(5): 1485-1489. DOI: 10.16438/j.0513-4870.2024-1190
Citation: REN Shi-jie, WEI Hong-ke, CHENG Xin-xin, WANG Jia-qi, QIAO Xiao-ting, WANG Xiao-min, LÜ Zi-yu, CAO Duo. A new sesquiterpenes from Pteris wallichiana and its anticancer activityJ. Acta Pharmaceutica Sinica, 2025, 60(5): 1485-1489. DOI: 10.16438/j.0513-4870.2024-1190

西南凤尾蕨中一个新的倍半萜及其抗癌活性研究

A new sesquiterpenes from Pteris wallichiana and its anticancer activity

  • 摘要: 采用MCI树脂、葡聚糖凝胶Sephadex LH 20、Flash C18制备色谱和半制备液相制备色谱等方法, 对西南凤尾蕨根部甲醇提取物进行较为系统的分离纯化, 通过质谱、红外光谱和核磁共振等方法, 对分离到的化合物进行结构鉴定。从西南凤尾蕨中分离鉴定了5个倍半萜类化合物, 分别为6,7-四氢吡喃环-(2S, 3S)-蕨素C-3-O-β-D-(6′-acetyl)-葡萄糖苷(1)、(2S, 3S)-蕨素C-3-O-β-D葡萄糖苷(2)、(2S)-蕨素A (3)、(2S)-13-羟基蕨素A (4) 和(2R, 3S)-2-羟基蕨素C (5)。其中, 化合物1为新的三环倍半萜, 化合物3~5首次从西南凤尾蕨中分离。体外生物活性实验表明, 化合物1能够抑制4T1和EMT6细胞增殖, 具有显著抗三阴性乳腺癌生物活性。

     

    Abstract: The methanol extract of Pteris wallichiana was separated and purified by MCI gel, sephadex LH 20, flash C18 and silica gel column chromatography combined with semi-pre HPLC. The chemical structures of the isolated compounds were identified by MS, IR, NMR, etc. Five sesquiterpene compounds were isolated from Pteris wallichiana and identified as 6,7-tetrahydrofuran-(2S, 3S)-pterosin C-3-O-β-D-(6′-acetyl)-Glu (1), (2S, 3S)-pterosin C-3-O-β-D-Glu (2), (2S)-pterosin A (3) and (2S)-13-hydroxyl-pterosin A (4), (2R, 3S)-2-hydroxyl-pterosin C (5). Compound 1 is a new sesquiterpene, compounds 3-5 were isolated for the first time. In vitro bioactivity assay showed that compound 1 was able to inhibit the proliferation of 4T1 and EMT6 cells, and possessed significant anti-triple-negative breast cancer bioactivity.

     

/

返回文章
返回